HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tjoa, B. A. Articles by Murphy, G. P. Search for Related Content PubMed PubMed Citation Articles by Tjoa, B. A. Articles by Murphy, G. P.

CA: A Cancer Journal for Clinicians, Vol 49, Issue 2 117-128, Copyright © 1999 by American Cancer Society

ARTICLES

Dendritic cell-based immunotherapy for prostate cancer

B. A. Tjoa, P. A. Lodge, M. L. Salgaller, A. L. Boynton and G. P. Murphy
Pacific Northwest Cancer Foundation, Cancer Research Division, Northwest Hospital, Seattle, WA, USA.

Dendritic cells are unique in their ability to stimulate naive T cells. These investigators have developed a prostate cancer vaccine using autologous dendritic cells as a vehicle to present prostate antigens to T cells in vivo.

This article has been cited by other articles:

				N. J. Nesslinger, R. A. Sahota, B. Stone, K. Johnson, N. Chima, C. King, D. Rasmussen, D. Bishop, P. S. Rennie, M. Gleave, et al. Standard Treatments Induce Antigen-Specific Immune Responses in Prostate Cancer Clin. Cancer Res., March 1, 2007; 13(5): 1493 - 1502. [Abstract] [Full Text] [PDF]

				A. Grolleau, D. E. Misek, R. Kuick, S. Hanash, and J. J. Mule Inducible Expression of Macrophage Receptor Marco by Dendritic Cells Following Phagocytic Uptake of Dead Cells Uncovered by Oligonucleotide Arrays J. Immunol., September 15, 2003; 171(6): 2879 - 2888. [Abstract] [Full Text] [PDF]